AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers.
about
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomicsGene therapy of inherited retinal degenerations: prospects and challengesPotential role of Cyr61 induced degeneration of human Müller cells in diabetic retinopathy.Vector platforms for gene therapy of inherited retinopathies.Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV Restores ON and OFF visual responses in blind miceVitreal delivery of AAV vectored Cnga3 restores cone function in CNGA3-/-/Nrl-/- mice, an all-cone model of CNGA3 achromatopsiaIL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling.Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injectionDystrophin Dp71 Isoforms Are Differentially Expressed in the Mouse Brain and Retina: Report of New Alternative Splicing and a Novel Nomenclature for Dp71 Isoforms.Altered astrocyte morphology and vascular development in dystrophin-Dp71-null mice.Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primatesAAV-mediated gene therapy in Dystrophin-Dp71 deficient mouse leads to blood-retinal barrier restoration and oedema reabsorption.Using Adeno-associated Virus as a Tool to Study Retinal Barriers in DiseaseHighly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina.Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1.Noninvasive gene delivery to foveal cones for vision restoration.
P2860
Q26998543-8AF9C9AD-7710-44B1-B7AD-9B410E295CACQ27009261-EE5D7384-75F7-43FF-9D89-A1F7B42A89C5Q34351536-2C553C88-363D-42BE-A181-44E3BAF70208Q34561531-4D5E89CC-D543-487F-A58B-63845DFF8813Q34734029-3391538F-6275-44C6-B756-0A7CDE393BE3Q35693904-AA67D189-1EC0-479B-8F5B-9A0639D0BABDQ37538552-9217141D-32F9-42E4-87CA-BDBD9DA44EB5Q37731427-04C1C294-2925-4433-BBD0-DE53EE5C8771Q38719209-B1AFE3B8-3253-465E-A9FA-CF1DD350D473Q39024301-5853027C-CD1E-452A-B2C3-E04D854B982EQ39076892-22DE5747-F9BE-48AB-9AB3-BA9A6F2E7C05Q39545161-DFA606EC-D3E6-40D0-B290-187599A64E93Q39545167-92C0D483-3B6D-4085-849B-56C98E53681FQ40641248-88DB92DC-3244-452C-A17D-256F65C08D09Q41122957-F306C67B-1532-4698-9CBD-C6A76F296DBBQ47549141-66F4A8B8-99F6-441C-915B-1D916CF7316D
P2860
AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers.
@en
AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers.
@nl
type
label
AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers.
@en
AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers.
@nl
prefLabel
AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers.
@en
AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers.
@nl
P2093
P2860
P50
P356
P1433
P1476
AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers.
@en
P2093
Alvaro Rendon
Marie Darche
Ophélie Vacca
P2860
P304
P356
10.1002/GLIA.22617
P577
2013-12-31T00:00:00Z